Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination

This study has been completed.
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: April 29, 2010
Last updated: October 23, 2014
Last verified: October 2013